Directorio de personas
Judit Ribas Fortuny

Judit Ribas Fortuny

Grado: Doctor/a

973 702 404
judit.ribas(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-3362-2011

Publicaciones

  • Martínez-Escardó L; Alemany M; Sánchez-Osuna M; Sánchez-Chardi A; Roig-Martínez M; Suárez-García S; Ruiz-Molina D; Vidal N; Plans G; Majós C; Ribas J; Baltrons MA; Bayascas JR; Barcia C; Bruna J; Yuste VJ

    Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells.

    Cancers 13 -. .

    [doi:10.3390/cancers13215579]

  • Chicote J; Yuste VJ; Boix J; Ribas J

    Cell Death Triggered by the Autophagy Inhibitory Drug 3-Methyladenine in Growing Conditions Proceeds With DNA Damage.

    Frontiers in Pharmacology 11 580343-580343. .

    [doi:10.3389/fphar.2020.580343]

  • Mattiolo P; Yuste VJ; Boix J; Ribas J

    Autophagy exacerbates caspase-dependent apoptotic cell death after short times of starvation

    BIOCHEMICAL PHARMACOLOGY 98 573-586. .

    [doi:10.1016/j.bcp.2015.09.021]

  • Garcia-Belinchon M; Sanchez-Osuna M; Martinez-Escardo L; Granados-Colomina C; Pascual-Guiral S; Iglesias-Guimarais V; Casanelles E; Ribas J; Yuste VJ

    An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death

    Journal Of Biological Chemistry 290 20841-20855. .

    [doi:10.1074/jbc.M115.644179]

  • Ribas J; Mattiolo P; Boix J

    Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment

    CURRENT DRUG TARGETS 16 31-37. .

    [doi:10.2174/1389450115666141114153536]

  • Zheng, Q.; Peskoe, S.B.; Ribas, J.; Rafiqi, F.; Kudrolli, T.; Meeker, A.K.; De Marzo, A.M.; Platz, E.A.; Lupold, S.E.

    Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy

    Prostate 74 1655-1662. .

    [doi:10.1002/pros.22883]

  • Mattiolo, P.; Barbero-Farran, A.; Amigó, J.; Ripamonti, M.; Ribas, J.; Boix, J.

    Cell death induced by 2-phenylethynesulfonamide uncovers a pro-survival function of BAX

    CANCER LETTERS 354 115-121. .

    [doi:10.1016/j.canlet.2014.07.037]

  • Mattiolo, P.; Barbero-Farran, A.; Yuste, V.J.; Boix, J.; Ribas, J.

    2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53

    BIOCHEMICAL PHARMACOLOGY 91 301-311. .

    [doi:10.1016/j.bcp.2014.08.005]

  • Brebi P; Maldonado L; Noordhuis MG; Ili C; Leal P; Garcia P; Brait M; Ribas J; Michailidi C; Perez J; Soudry E; Tapia O; Guzman P; Muñoz S; Van Neste L; Van Criekinge W; Irizarry R; Sidransky D; Roa JC; Guerrero-Preston R

    Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population

    EPIGENETICS 9 308-317. .

    [doi:10.4161/epi.27120]

  • Ribas, Judit; Ni, Xiaohua; Castanares, Mark; Liu, Minzhi M.; Esopi, David; Yegnasubramanian, Srinivasan; Rodriguez, Ronald; Mendell, Joshua T.; Lupold, Shawn E.

    A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts

    NUCLEIC ACIDS RESEARCH 40 6821-6833. .

    [doi:10.1093/nar/gks308]

  • Garrofe-Ochoa, Xenia; Cosialls, Ana M.; Ribas, Judit; Gil, Joan; Boix, Jacint

    Transcriptional modulation of apoptosis regulators by roscovitine and related compounds.

    Apoptosis 16 660-670. .

    [doi:10.1007/s10495-011-0603-3]

  • Ni X; Zhang Y; Ribas J; Chowdhury WH; Castanares M; Zhang Z; Laiho M; DeWeese TL; Lupold SE

    Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

    JOURNAL OF CLINICAL INVESTIGATION 121 2383-2390. .

    [doi:10.1172/JCI45109]

Proyectos

  • Reposicionamiento contra el Crohn: cribado de una librería de fármacos aprobados por FDA que frenen la muerte celular por TNF-a en modelos genéticos deficientes en autofagia
  • Identificación de los determinantes moleculares ligados a autofagia que modulan la sensibilidad frente a los fármacos antitumorales convencionales (AUTOPHAGYPHARMA)
  • Regulación de la Autofagia por los genes TMEM49 y miR-21 (RAGETMEM49MIR21)